Ligand · R5R
R5R · Zolpidem
R5R, Zolpidem (C19 H21 N3 O, 307.4 g/mol), in the MolNFT structures on GenesisL1: bound in 5 records (4 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.
- Component
- R5R
- Formula
- C19 H21 N3 O
- Class
- ligand
- Structures
- 5
- PDB entries
- 4
Binding sites
R5R in 5 structures; the first of them:
- 8DD2 · Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem · R5R A402 · binds THR262, ASN265, ASP282, LEU285, MET286, PHE289, VAL290, ILE228 and 5 more
- 8G4N · Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with… · R5R C502 · binds PHE99, HIS101, SER158, TYR159, VAL202, GLN203, SER204, SER205 and 9 more
- 8G5G · Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in… · R5R C601 · binds ASP56, MET57, TYR58, PHE77, ALA79, MET130, THR142, PHE124 and 8 more
- 8G5H · Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in… · R5R C602 · binds PHE99, HIS101, SER158, TYR159, VAL202, GLN203, SER204, SER205 and 9 more
- 8DD2 · Human gabaa receptor ALPHA1-BETA2-GAMMA2 subtype in complex with GABA plus zolpidem · R5R A402 · binds THR262, ASN265, ASP282, LEU285, MET286, PHE289, ILE228, LEU232 and 3 more
Residues it binds most
THR 9, MET 9, PHE 9, SER 5, TYR 5, ASP 8, LEU 4, GLN 7, ASN 6, VAL 6 (residue and the binding sites it lines).
Found with
- ABU · Gamma-amino-butanoic acid
- BMA · beta-D-mannopyranose
- MAN · alpha-D-mannopyranose
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose
- PIO · [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2, 3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate
- Y4B · allopregnanolone
- FUC · alpha-L-fucopyranose
- D12 · Dodecane
- POV · (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate
- OCT · N-octane
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.